Security key
86150R107
Stoke Therapeutics, Inc. - COMMON STOCK (STOK)
CUSIP: 86150R107
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 45,032,645
- Total 13F value
- $236,869,874
- Share change
- +1,079,596
- Put/Call ratio
- 88%
- SEC-reported price per share
- $5.26
- Number of holders
- 81
- Value change
- +$6,784,370
- Number of buys
- 33
- Number of sells
- 51
- Shares outstanding
- 64,272,828
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
81
Top holders
10
STOK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Ownership snapshot
Top reported holders of STOK - Stoke Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Skorpios Trust
Disclosed value leader
Skorpios Trust
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $56,908,103
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Skorpios Trust has the largest disclosed position value at $56.91M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Skorpios Trust's linked filing trail.
Disclosed position value
Top 5
Skorpios Trust
$56.91M
RTW INVESTMENTS, LP
$17.3M
Redmile Group, LLC
$15.26M
COWEN AND COMPANY, LLC
$14.66M
MORGAN STANLEY
$11.48M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Skorpios Trust |
13F
Company
|
—
denominator unverified
|
$56,908,103
14,443,681 shares
|
— | 30 Sep 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
—
denominator unverified
|
$17,298,799
4,390,558 shares
|
— | 30 Sep 2023 |
| Redmile Group, LLC |
13F
Company
|
—
denominator unverified
|
$15,258,422
3,872,696 shares
|
— | 30 Sep 2023 |
| COWEN AND COMPANY, LLC |
13F
Company
|
—
denominator unverified
|
$14,663,336
3,721,659 shares
|
— | 30 Sep 2023 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$11,480,309
2,913,784 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$8,693,651
2,206,510 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
81
Shares
45,032,645
Rows available
81
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
96
Q4 2023 holders
81
Holder diff
-15
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend